| Discovery of novel PTP1B inhibitors with antihyperglycemic activity. | |
| | |
MedLine Citation:
|
PMID: 20686525 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
AIM: To discover and optimize a series of novel PTP1B inhibitors containing a thiazolidinone-substituted biphenyl scaffold and to further evaluate the inhibitory effects of these compounds in vitro and in vivo. METHODS: A total of 36 thiazolidinone substituted biphenyl scaffold derivatives were prepared. An in vitro biological evaluation was done by Enzyme-based assay. The in vivo efficacy of 7Fb as an antihyperglycemic agent was evaluated in a BKS db/db diabetic mouse model with a dose of 50 mg.kg(-1).d(-1) for 4 weeks. RESULTS:The in vitro biological evaluation showed that compounds 7Fb and 7Fc could increase the insulin-induced tyrosine phosphorylation of IRbeta in CHO/hIR cells. In in vivo experiments, compound 7Fb significantly lowered the postprandial blood glucose, from 29.4+/-1.2 mmol/L with the vehicle to 24.7+/-0.6 mmol/L (P<0.01), and the fasting blood glucose from 27.3+/-1.5 mmol/L with the vehicle to 23.6+/-1.2 mmol/L (P<0.05). CONCLUSION: A novel series of compounds were discovered to be PTP1B inhibitors. Among them, compound 7Fb significantly lowered the postprandial and fasting glucose levels, and the blood glucose level declined more rapidly than in metformin-treated mice. Thus, 7Fb may be a potential lead compound for developing new agents for the treatment of type II diabetes. |
| | |
Authors:
|
Zhang Liu; Qian Chai; Yuan-yuan Li; Qiang Shen; Lan-ping Ma; Li-na Zhang; Xin Wang; Li Sheng; Jing-ya Li; Jia Li; Jing-kang Shen |
Related Documents
:
|
18669585 - Defective activity of recombinant cytochromes p450 3a4.2 and 3a4.16 in oxidation of mid... 9815185 - Biodistribution of, antimutagenic efficacies in salmonella typhimurium of, and inhibiti... 12099975 - Brain-derived neurotrophic factor ameliorates lipid metabolism in diabetic mice. 20407615 - Diabetes accelerates retinal neuronal cell death in a mouse model of endogenous hyperho... 15110095 - Cyp1a2 and nat2 genotype/phenotype relations and urinary excretion of 2-amino-1-methyl-... 2687065 - Plasma adrenaline kinetics in type 1 (insulin-dependent) diabetic patients with and wit... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Acta pharmacologica Sinica Volume: 31 ISSN: 1745-7254 ISO Abbreviation: Acta Pharmacol. Sin. Publication Date: 2010 Aug |
Date Detail:
|
Created Date: 2010-08-05 Completed Date: 2010-11-12 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100956087 Medline TA: Acta Pharmacol Sin Country: United States |
Other Details:
|
Languages: eng Pagination: 1005-12 Citation Subset: IM |
Affiliation:
|
Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Blood Glucose / drug effects Diabetes Mellitus, Experimental / drug therapy Diabetes Mellitus, Type 2 / drug therapy* Drug Design Enzyme Inhibitors / chemical synthesis, chemistry, pharmacology* Hypoglycemic Agents / chemical synthesis, chemistry, pharmacology* Mice Mice, Inbred C57BL Protein Tyrosine Phosphatase, Non-Receptor Type 1 / antagonists & inhibitors* Thiazolidines / chemical synthesis, chemistry, pharmacology |
| Chemical | |
Reg. No./Substance:
|
0/Blood Glucose; 0/Enzyme Inhibitors; 0/Hypoglycemic Agents; 0/Thiazolidines; EC 3.1.3.48/Protein Tyrosine Phosphatase, Non-Receptor Type 1 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Novel vehicle based on cubosomes for ophthalmic delivery of flurbiprofen with low irritancy and high...
Next Document: Slow progress.